1-20 of 27
Sort by
News

October 2023 Data Stream

Published: 2023
Abstract
October 2023
View News titled, October 2023 Data Stream
News

Biden-Harris Administration Contributes $50 Million to Persistent Poverty Initiative

Published: 2023
Abstract
October 2023
View News titled, Biden-Harris Administration Contributes $50 Million to Persistent Poverty Initiative
News

UMich Rogel Cancer Center Awarded $37 Million

Published: 2023
Abstract
October 2023
View News titled, UMich Rogel Cancer Center Awarded $37 Million
News

Remembering Adel Yunis (1930-2023)

Published: 2023
Abstract
October 2023
View News titled, Remembering Adel Yunis (1930-2023)
News

DKMS Honors Carl H. June for Immunology Achievements

Published: 2023
Abstract
October 2023
View News titled, DKMS Honors Carl H. June for Immunology Achievements
News

KU Receives $100 Million for New Cancer Center

Published: 2023
Abstract
October 2023
View News titled, KU Receives $100 Million for New Cancer Center
News

Checking Boxes

Published: 2023
Abstract
October 2023
View News titled, Checking Boxes
News

Would you extend anticoagulation in a patient who had a native aortic valve thrombus while on DHEA?

Published: 2023
Abstract
October 2023
View News titled, Would you extend anticoagulation in a patient who had a native aortic valve thrombus while on DHEA?
News

You Make the Call: Would you extend anticoagulation in a patient who had a native aortic valve thrombus while on DHEA?

Published: 2023
Abstract
October 2023
View News titled, You Make the Call: Would you extend anticoagulation in a patient who had a native aortic valve thrombus while on DHEA?
News

Venetoclax Reverses Negative Prognostic Impact of Splicing Factor Mutations for Patients with Acute Myeloid Leukemia

Anna Azvolinsky, PhD
Published: 2023
Abstract
October 2023
View News titled, Venetoclax Reverses Negative Prognostic Impact of Splicing Factor Mutations for Patients with Acute Myeloid Leukemia
News

Tafasitamab, Lenalidomide Plus Firstline R-CHOP Feasible in Diffuse Large B-Cell Lymphoma

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Tafasitamab, Lenalidomide Plus Firstline R-CHOP Feasible in Diffuse Large B-Cell Lymphoma
News

Will Pola-R-CHP Be the New Standard Upfront Treatment for Diffuse Large B-Cell Lymphoma?

Published: 2023
Abstract
October 2023
View News titled, Will Pola-R-CHP Be the New Standard Upfront Treatment for Diffuse Large B-Cell Lymphoma?
News

Database Analysis Supports Use of Immunochemotherapy for Primary Central Nervous System Lymphoma

Anna Azvolinsky, PhD
Published: 2023
Abstract
October 2023
View News titled, Database Analysis Supports Use of Immunochemotherapy for Primary Central Nervous System Lymphoma
News

Mending the Pain

Published: 2023
Abstract
October 2023 Below, Akshat Jain, MD, MPH, a pediatric hematologist at Loma Linda University School of Medicine and Children’s Hospital in California, shares a recent poem of his that was written in tribute to patients with sickle cell disease.
View News titled, Mending the Pain
News

Infection Risk Linked to Bispecific Antibody Use in Multiple Myeloma

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Infection Risk Linked to Bispecific Antibody Use in Multiple Myeloma
News

2023 Choosing Wisely Champions Improve Quality of Care and Patient Outcomes

Published: 2023
Abstract
October 2023
View News titled, 2023 Choosing Wisely Champions Improve Quality of Care and Patient Outcomes
News

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study
News

New Strategy Boosts Anti-BCMA CAR T-Cell Activity for Patients with Multiple Myeloma

Anna Azvolinsky, PhD
Published: 2023
Abstract
October 2023
View News titled, New Strategy Boosts Anti-BCMA CAR T-Cell Activity for Patients with Multiple Myeloma
News

Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A
News

Investigational BCMA-Directed CAR T-Cell Therapy for R/R Multiple Myeloma Provides Deep Responses, Low Toxicity

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Investigational BCMA-Directed CAR T-Cell Therapy for R/R Multiple Myeloma Provides Deep Responses, Low Toxicity